The use of Artificial Intelligence (AI) for personalized medicine has recently guided improvements in the diagnostic pathway of many diseases. The EU Project GENOMED4ALL: “Genomics and Personalized Medicine for All through Artificial Intelligence in Haematological Diseases” aims at using European data of patients affected by Sickle Cell Disease (SCD) to find correlation between -omics data – and phenotype, seizing the opportunity to improve diagnostics through AI.
S265: RADIOMICS AND ARTIFICIAL INTELLIGENCE FOR IDENTIFICATION AND MONITORING OF SILENT CEREBRAL INFARCTS IN SICKLE CELL DISEASE: FIRST ANALYSIS FROM THE GENOMED4ALL EUROPEAN PROJECT / Boaro, M. P.; Biondi, R.; Biondini, N.; Collado Gimbert, A.; JM, E. F.; Pinto, V.; Romano, N.; Voi, V.; Ferrero, G. B.; Casale, M.; Cirillo, M.; Palazzi, G.; Cavalleri, F.; Forni, G. L.; Reggiani, G.; Perrotta, S.; Manu Pereira, M.; Zazo, S.; Marias, K.; De Montalembert, M.; Bartolucci, P.; van Beers, E.; Alvarez, F.; Cremonesi, F.; Sanavia, T.; Fariselli, P.; Castellani, G.; Manara, R.; Colombatti, R.. - In: HEMASPHERE. - ISSN 2572-9241. - ELETTRONICO. - 6:(2022), pp. 166-167. [10.1097/01.HS9.0000843952.59228.1d]
S265: RADIOMICS AND ARTIFICIAL INTELLIGENCE FOR IDENTIFICATION AND MONITORING OF SILENT CEREBRAL INFARCTS IN SICKLE CELL DISEASE: FIRST ANALYSIS FROM THE GENOMED4ALL EUROPEAN PROJECT
Biondi, R.;Castellani, G.;
2022
Abstract
The use of Artificial Intelligence (AI) for personalized medicine has recently guided improvements in the diagnostic pathway of many diseases. The EU Project GENOMED4ALL: “Genomics and Personalized Medicine for All through Artificial Intelligence in Haematological Diseases” aims at using European data of patients affected by Sickle Cell Disease (SCD) to find correlation between -omics data – and phenotype, seizing the opportunity to improve diagnostics through AI.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
